Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry

References

• Mansour SC, Pena OM, Hancock RE. Host defence peptides: front-line immunomodulators. Trends Immunol 2014;35(9):443–450.
   PubMed Web of Science ®Google Scholar
• Kuroda K, Okumura K, Isogal H. The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs. Front Oncol 2015;5:144. doi:10.3389/fonc.2015.00144.
   PubMed Web of Science ®Google Scholar
• Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D, et al. Emerging roles of the hose defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer 2010;127:1741–1747.
   PubMed Web of Science ®Google Scholar
• Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, et al. Regulation of neovascularization by human neutrophil peptides (alpha defensins): a link between inflammation and angiogenesis. Faseb 2004;18(11):1306–1308.
   PubMed Web of Science ®Google Scholar
• Mader J, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Exp Opin Invest Drugs 2006;15:933–946.
   PubMed Web of Science ®Google Scholar
• Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, Vlajkovic S, Cekic S, Stefanovic V. Ocular Melanoma: an overview of the current status. Int J Clin Exp Pathol 2013;6(7):1230–1244.
   PubMed Web of Science ®Google Scholar
• Kim JE, Kim HJ, Choi JM, Lee KH, Kim TY, Cho BK, et al. The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma. Br J Dermatol 2010;163(5):959–967.
   PubMed Web of Science ®Google Scholar
• Gerashchenko O, Zhuravel E, Skachkova O, Kharanovska N, Pushkarev V, Pogrebnoy P, et al. Involvement of human beta defensin-2 in regulation of malignant potential of cultured human melanoma cells. Exp Oncol 2014;36(1):17–23.
   PubMedGoogle Scholar
• Weber G, Chamorro CI, Granath F, Liljegren A, Zreika S, Saidak Z, et al. Human antimicrobial peptide hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer Res 2009;11(1):R6.
   PubMed Web of Science ®Google Scholar
• Hendrix MJ, Seftor EA, Seftor RE, Chao JT, Chien DS, Chu YW. Tumor cell vascular mimicry: novel targeting opportunity in melanoma. Pharmacol Ther 2016;159:83–92.
   PubMed Web of Science ®Google Scholar
• Folberg R, Maniotis MJ. Vasculogenic mimicry. Apmis 2004;112:508–525.
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi F, et al. Hemodynamics in vasculogenic mimicry and angiogenesis in inflammatory breast cancer xenograft. Cancer Res 2002;62:560–566.
   PubMed Web of Science ®Google Scholar
• Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J, et al. Vascular channel formation by human melanoma cells in vitro and in vivo: vasculogenic mimicry. Am J Pathol 1999;155:739–752.
   PubMed Web of Science ®Google Scholar
• Thies A, Mangold U, Moll I, Schumacher U. PAS positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 2001;195:537–542.
   PubMed Web of Science ®Google Scholar
• Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, et al. Tumor cell vasculogenic mimicry: a controversy to therapeutic promise. Am J Pathol 2012;181(4):1115–1125.
   PubMed Web of Science ®Google Scholar
• Koczulla R, Von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003;111(11):1665–1672.
   PubMed Web of Science ®Google Scholar
• Li J, Post M, Volk R, Gao Y, Li M, Metais C, et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000;6:49–55.
   PubMed Web of Science ®Google Scholar
• Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K, Azuma I. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibits tumor metastasis in mice. Jpn J Cancer Res 1997;88:184–190.
   PubMedGoogle Scholar
• Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330(6009):1410–1413.
   PubMed Web of Science ®Google Scholar
• Redfern RL, Reins RY, McDermott AM. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res 2011;92(3):209–220.
   PubMed Web of Science ®Google Scholar
• Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci 2006;47:2369–2380.
   PubMed Web of Science ®Google Scholar
• Narayanan S, Miller WL, McDermott AM. Expression of human beta defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci 2003;44:3795–3801.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Nagase T, Mikita R. Identification of multiple novel epididymis-specific beta defensin isoforms in humans and mice. J Immunol 2002;169:2516–2523.
   PubMed Web of Science ®Google Scholar
• De Jonge H, Fehrmann R, De Bont E, Hofstra R, Gerbens F, Kamps WA, et al. Evidence based selection of housekeeping genes. Plos One 2007;9:e898.
   Web of Science ®Google Scholar
• Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30(9):e36;.
   PubMed Web of Science ®Google Scholar
• Folberg R, Kadkol SS, Frenkel S, Valyi-Nagy K, Jager MJ, Pe’er J, et al. Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci 2008;49(11):4697–4701.
   PubMed Web of Science ®Google Scholar
• Yu X, Ambrosini G, Roszik J, Eterovic AK, Stempke-Hale K, Seftor EA, et al. Genetic analysis of the ‘uveal melanoma’ C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line. Pigment Cell Melanoma Res 2015;28(3):357–359.
   PubMed Web of Science ®Google Scholar
• Semlali A, Al Amri A, Azzi A, Al Shahrani O, Arafah M, Kohailan M, et al. Expression and new exon mutations of the human Beta defensins and their association with colon cancer development. Plos One 2015;10(6):e0126868.
   PubMed Web of Science ®Google Scholar
• Melle C, Ernst G, Schimmel B, et al. Discovery and identification of alpha-defensins as low abundant, tumour-derived serum markers in colorectal cancer. Gastro 2005;129(1):66–73.
   PubMed Web of Science ®Google Scholar
• Muller CA, Markovic-Lipkovski J, Klatt T, Gamper J, Schwarz G, Bech K, et al. Human alpha defensin HNPs −1, −2, −3 in renal cell carcinoma. Am J Pathol 2002;160(4):1311–1324.
   PubMed Web of Science ®Google Scholar
• Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schelhammer PF, Corica A, et al. Overexpression of alpha-defensin is associated with bladder cancer invasiveness. Urol Oncol 2006;24(2):97–108.
   PubMed Web of Science ®Google Scholar
• Lundy FT, Orr DF, Gallagher JR, Maxwell P, Shaw C, Napier SS, et al. Identification and overexpression of human neutrophil alpha-defensins (HNP-1, 2, and 3) in squamous cell carcinomas of the human tongue. Oral Oncology 2004;40(2):139–144.
   PubMed Web of Science ®Google Scholar
• Shestakova T, Zhuravel E, Bolgova L, Alekseeno O, Soldatkina M, Pogrebnoy P. Expression of human beta defensin −1, 2, and 4 mRNA in human lung tumor tissue: a pilot study. Exper Oncol 2008;30(2):153–156.
   PubMedGoogle Scholar
• Hauck SM, Ueffing M, Suppmann S. Proteomic profiling of primary retinal Muller glia cells reveals a shift in expression patterns upon adaptation to in vitro conditions. Glia 2003;44(3):251–263.
   PubMed Web of Science ®Google Scholar
• Sainz B Jr, Alcala S, Garcia E, Sanchez-Ripoll Y, Azevedo MM, Cioffi M, et al. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Gut 2015;64:1921–1935.
   PubMed Web of Science ®Google Scholar
• Li D, Liu W, Wang X, Wu J, Quan W, Yao Y, et al. Cathelicidin, an antimicrobial peptide produced by macrophages, promotes colon cancer by activating the Wnt/beta catenin pathway. Oncotarget 2015;6(5):2939–2950.
   PubMed Web of Science ®Google Scholar
• Folberg R, Leach L, Valyi-Nagy K, Lin AY, Apushkin MA, Ai Z, et al. Modeling the behavior of uveal melanoma in the liver. Invest Ophthalmol Vis Sci 2007;48(7):2967–2974.
   PubMed Web of Science ®Google Scholar
• Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, et al. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 2002;72(1):167–174.
   PubMed Web of Science ®Google Scholar
• Radeva MY, Jahns F, Wilhelm A, Glei M, Settmacher U, Greulich KO, et al. Defensin alpha 6 (DEFA6) overexpression threshold of over 60 fold can distinguish between adenoma and full blown colon carcinoma in individual patients. BMC Cancer 2010;10:588.
   PubMed Web of Science ®Google Scholar
• Hensel JA, Chanda D, Kumar S, Sawant A, Grizzle WE, Siegel GP, et al. LL-37 as a therapeutic target for late stage cancer. Prostate 2011;71(6):659–670.
   PubMed Web of Science ®Google Scholar
• Stangegaard M, Dufva IH, Dufva M. Reverse transcription using random pentadecamer primers increases yield and quality of resulting cDNA. Biotechniques 2006;40(5):649–657.
   PubMed Web of Science ®Google Scholar
• White JS, Becker RL, McLean IW. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines. Cancer Genet Cytogenet 2006;168(1):11–21.
   PubMedGoogle Scholar
• Nareyeck G, Zeschnigk M, Prescher G, Lohmann DR, Anastassiou G. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3. Exp Eye Res 2006;83(4):858–864.
   PubMed Web of Science ®Google Scholar
• Jager MH, Magner AB, Ksander BR, Dubovy SR. Uveal melanoma cell lines: where do they come from? (An American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2016;114:T5[1–16].
   PubMedGoogle Scholar
• Suesskind D, Gauss S, Faust UEA, Bauer P, Schrader M, Bartz-Schmidt KU, et al. Characterization of novel uveal melanoma cell lines under serum-free conditions. Graefe’s Arch Clin Exp Ophthalmol 2013;251(8):2063–2070.
   PubMed Web of Science ®Google Scholar
• Bronkhorst IH, Jager MJ. Inflammation in uveal melanoma. Eye 2013;27(2):217–223.
   PubMed Web of Science ®Google Scholar